A case report of intracranial infection caused by Shewanella putrefaciens

Duan, Mengxi; Wang, Dali; Wang, Jing; Xiao, Xiaoguang; Han, Li; Zhang, Fenghua

doi:10.1007/s10072-014-1956-5

Cited by 10 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On this basis, it can be assumed that the majority of S. putrefaciens infections listed in this review are indeed infections caused by S. algae . Only in one case report, 16S rDNA amplification assay was performed ( Duan et al., 2015 ). In some case reports, no information was provided on the identification method ( Supplementary Table 1 ).…”

Section: Discussionmentioning

confidence: 99%

Shewanella putrefaciens, a rare human pathogen: A review from a clinical perspective

Müller

Bonin²,

Schneider³

et al. 2023

Front. Cell. Infect. Microbiol.

View full text Add to dashboard Cite

Shewanella putrefaciens is a gramnegative, facultatively anaerobic, rod shaped bacterium. It belongs to the class of the Gammaproteobacteria and was first described in 1931. S. putrefaciens is part of the marine microflora and especially present in moderate and warm climates. The bacterium is a rare oppurtonistic human pathogen associated mainly with intra-abdominal as well as skin and soft tissue infections. However, it has also been reported in association with more severe diseases such as pneumonia, intracerebral and ocular infections and endocarditis. In these cases the clinical courses are often associated with underlying, predisposing diseases and risk factors. For successful treatment of S. putrefaciens, a combination of appropriate local therapy, e.g. surgical treatment or drainage, and antibiotic therapy should be performed. Since multiple resistances to antibiotics are described, the results of the antimicrobial susceptibility testing must be considered for effective therapy as well. Furthermore, a main challenge in clinical practice is the accurate microbiological identification, and especially the correct differentiation between S. putrefaciens and S. algae. Under certain circumstances, Shewanella-infections can have severe, sometimes even fatal consequences. Therefore, we decided to present the current state of knowledge as well as further aspects with regard to future diagnostics, therapy and research.

show abstract

Section: Discussionmentioning

confidence: 99%

Shewanella putrefaciens, a rare human pathogen: A review from a clinical perspective

Müller

Bonin²,

Schneider³

et al. 2023

Front. Cell. Infect. Microbiol.

View full text Add to dashboard Cite

show abstract

“…Patients with STBI are critically ill and often affected by increased intracranial pressure and toxic metabolites, resulting in sustained brain injury (12,13). Intracranial infection, one of the complications of cranial operation, is treated with the complete elimination of surgical infected wounds, with antibiotic, symptomatic and supportive treatments (14). Intracranial infection usually occurs within 3–7 days after cranial operation (15), accompanied by fever, disturbance of consciousness and other clinical manifestations.…”

Section: Discussionmentioning

confidence: 99%

Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury

et al. 2019

View full text Add to dashboard Cite

This study investigated the improvement and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury (STBI). A retrospective analysis was performed on 86 patients with intracranial infections after cranial trauma operation in Tai'an Traditional Chinese Medicine Hospital and Affiliated Hospital of Taishan Medical University from May 2004 to June 2017. The patients were divided into the control group (43 patients) and the experimental group (43 patients) according to the treatment. Patients in the control group were intravenously infused with vancomycin hydrochloride (1.0 g, Q12H) and meropenem (2.0 g, Q8H). After lumbar cistern drainage was performed for the release of cerebrospinal fluid (CSF), patients in the experimental group were slowly given vancomycin 20 mg. After the tube was flushed with 2 ml of 0.9% sodium chloride injection, the patients were slowly given meropenem 20 mg, bid. The clinical efficacy, cure time and treatment cost of patients in the two groups were observed. The adverse reactions and sequelae after 6 months of treatment were recorded. The response rate (RR) of patients in the experimental group was significantly higher than that in the control group (P<0.05). The cure time of patients in the experimental group was significantly lower than that in the control group (P<0.05). The treatment cost of patients in the experimental group was significantly lower than that in the control group (P<0.05). The incidence of adverse reactions of patients, incidence of sequelae of patients in the experimental group was significantly lower than that in the control group (P<0.05). Intrathecal meropenem and vancomycin is more effective than intravenous administration in the treatment of intracranial infection after craniotomy. It can significantly shorten the treatment time and reduce the treatment cost, with better safety.

show abstract

“…The literature mentions only one case of nosocomial meningitis caused by Shewanella putrefaciens, which was secondary to a cerebral hemorrhage treated by neurosurgery. 5 Two cases of cerebral abscess secondary to purulent otitis 6,7 have also been described (including a Klebsiella pneumoniae coinfection). However, other instances of community-acquired Shewanella spp.…”

Section: Discussionmentioning

confidence: 99%

Case Report: Disseminated Shewanella algae Infection with Meningoencephalitis in a Traveler Secondary to Marine Injury in Madagascar

Brulliard

Traversier

Allyn

et al. 2017

The American Journal of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

Marine microorganisms such as spp., spp., and spp. can cause sepsis secondary to a wound infection in the context of swimming. These microorganisms are most often susceptible to fluoroquinolones. Here, we report a unique case of bacteremia associated with meningoencephalitis and disseminated via hematogenous spread secondary to a skin injury. The patient suffered the injury while swimming in saline water during a cruise holiday in Madagascar, and she was initially treated with amoxicillin. The neurological evolution was unsatisfactory. Better knowledge of such infections (and especially of the context in which they occur), as well as greater familiarity with the susceptibility profile of different marine microorganisms would have allowed health professionals to provide presumptive microbiological diagnosis and effective treatment earlier.

show abstract

A case report of intracranial infection caused by Shewanella putrefaciens

Cited by 10 publications

References 5 publications

Shewanella putrefaciens, a rare human pathogen: A review from a clinical perspective

Shewanella putrefaciens, a rare human pathogen: A review from a clinical perspective

Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury

Case Report: Disseminated Shewanella algae Infection with Meningoencephalitis in a Traveler Secondary to Marine Injury in Madagascar

Contact Info

Product

Resources

About